Company Active LTD

Company profile

Atmps Ltd

Cell and Gene Therapy Plaform - Hataali for ATMPs

An innovative, digital solution for ATMPs using blockchain. Used for clinical trials and commercial cell and gene therapies, rare diseases and regenerative treatments, it ensures data integrity, regulatory compliance. Hospitals can plan,order, schedule mulitple therapies using a single user portal.

CRN
12415491
Founded
2020
Age
6

Overview

Legal name
ATMPS LTD
Region
London
Registered address
71-75 SHELTON STREET
LONDON
GREATER LONDON
UNITED KINGDOM
WC2H 9JQ
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Oct
2026

Accounts due

Accounts Due

Next accounts due date

22 May
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

08 May
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Jan
2025

Accounts filed

Accounts

Last accounts made up date

21 Jan
2020

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2020
Funded years
2020, 2022
Age at first award
0 years

Projects

2022 Collaborative R&D Lead participant

Development and Proof of Concept testing of a novel Intelligent Biobank Platform

1 May 2022 to 31 Oct 2023

Awarded
£417,260
Total cost £596,085

Biological samples and the pre-clinical and clinical data generated from such samples are the key building blocks from which so much R&D builds on, especially in translating fundamental research into new innovations for personalised treatment and diagnosis of diseases. Biobanks are repositories of biological samples and their associated data, be they comm...

2020 Feasibility Studies Lead participant

Efficient Provision of Cancer Treatments post-COVID19 suspension

1 Jun 2020 to 30 Nov 2020

Awarded
£49,743
Total cost £49,743

A fully digital cancer treatment management solution which ensures patients are put at the centre of treatment, parties to the production, administration, transportation of samples and treatments are efficiently coordinated on a regulatory compliant platform.

Product types

Collaborative R&D Feasibility Studies